4/11
04:40 pm
qncx
Form PRE 14A Quince Therapeutics, For: Jun 05
Medium
Report
Form PRE 14A Quince Therapeutics, For: Jun 05
4/1
05:22 pm
qncx
Form S-8 Quince Therapeutics,
Medium
Report
Form S-8 Quince Therapeutics,
4/1
04:52 pm
qncx
Form 10-K Quince Therapeutics, For: Dec 31
Medium
Report
Form 10-K Quince Therapeutics, For: Dec 31
2/15
06:14 pm
qncx
Form 4 Quince Therapeutics, For: Feb 15 Filed by: Patni Rajiv
Low
Report
Form 4 Quince Therapeutics, For: Feb 15 Filed by: Patni Rajiv
2/15
06:09 pm
qncx
Form 3 Quince Therapeutics, For: Feb 15 Filed by: Patni Rajiv
Low
Report
Form 3 Quince Therapeutics, For: Feb 15 Filed by: Patni Rajiv
2/15
04:01 pm
qncx
Form 8-K Quince Therapeutics, For: Feb 13
Low
Report
Form 8-K Quince Therapeutics, For: Feb 13
2/14
04:02 pm
qncx
Form SC 13G/A Quince Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
Low
Report
Form SC 13G/A Quince Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
2/12
09:01 am
qncx
Form SC 13G Quince Therapeutics, Filed by: Sofinnova Partners SAS
Medium
Report
Form SC 13G Quince Therapeutics, Filed by: Sofinnova Partners SAS
2/7
10:50 am
qncx
Form SC 13G/A Quince Therapeutics, Filed by: BML Investment Partners, L.P.
Low
Report
Form SC 13G/A Quince Therapeutics, Filed by: BML Investment Partners, L.P.
2/2
06:02 pm
qncx
Form 4 Quince Therapeutics, For: Feb 01 Filed by: Ryan Charles S.
Low
Report
Form 4 Quince Therapeutics, For: Feb 01 Filed by: Ryan Charles S.
2/2
05:53 pm
qncx
Form 4 Quince Therapeutics, For: Feb 01 Filed by: Hannah Brendan
Low
Report
Form 4 Quince Therapeutics, For: Feb 01 Filed by: Hannah Brendan
2/2
05:51 pm
qncx
Form 4 Quince Therapeutics, For: Feb 01 Filed by: Thye Dirk
Low
Report
Form 4 Quince Therapeutics, For: Feb 01 Filed by: Thye Dirk
1/29
04:01 pm
qncx
Form 8-K Quince Therapeutics, For: Jan 23
Neutral
Report
Form 8-K Quince Therapeutics, For: Jan 23